SCHEMBL130267

SCHEMBL130267

O=C1C[C@H](c2ccccc2)Oc2c(O)cccc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 7/20 0.59
ADORA3 P0DMS8 3/20 0.59
AR P10275 3/20 0.59
MAOB P27338 2/20 0.59
KDM4E B2RXH2 2/20 0.59
HSD17B10 Q99714 2/20 0.59
MAPT P10636 3/20 0.56
CYP3A4 P08684 2/20 0.56
NPC1 O15118 1/20 0.56
MAPK1 P28482 1/20 0.56
RAB9A P51151 1/20 0.56
MAOA P21397 1/20 0.55
PSMB5 P28074 1/20 0.55
SYNJ2 O15056 2/20 0.54
POLB P06746 1/20 0.54
ALPI P09923 1/20 0.54
GAA P10253 1/20 0.54
RECQL P46063 1/20 0.54
BLM P54132 1/20 0.54
MCL1 Q07820 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9205670 1.00 CYP19A1 (0.59) CYP19A1ADORA3ARMAOBKDM4E
SCHEMBL1071068 0.91 CYP3A4 (0.65) CYP19A1ADORA3ARMAOBKDM4E
SCHEMBL15453089 0.85 MAPT (0.75) CYP19A1ADORA3KDM4EHSD17B10MAPT
SCHEMBL4951178 0.84 MAPT (0.74) CYP19A1ADORA3ARMAOBKDM4E
SCHEMBL1508800 0.82 CYP19A1 (0.64) CYP19A1ADORA3ARMAOBKDM4E
SCHEMBL10360963 0.81 MAOB (0.59) CYP19A1ADORA3ARMAOBKDM4E
SCHEMBL6703206 0.81 MAOB (0.59) CYP19A1ADORA3ARMAOBKDM4E
SCHEMBL15453038 0.79 PTPN1 (0.65) CYP19A1KDM4EMAPTPOLBALPI
SCHEMBL15453094 0.79 CYP19A1 (0.64) CYP19A1KDM4EHSD17B10MAPTCYP3A4
SCHEMBL8677834 0.79 MAOB (0.56) CYP19A1ADORA3ARMAOBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 337 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117242185-A Biocatalytic preparation of dihydrochalcone 西姆莱斯有限公司 2023-12-15 CN claimed
US-20260033492-A1 Pest Repellents and Uses Thereof SENSORYGEN INC (US) 2026-02-05 US disclosed
US-12280129-B2 Compositions and methods for improved skin care PINSKY MARK A (US) 2025-04-22 US disclosed
US-12156832-B2 Method, and system for multi-layer cosmetic pads and use thereof ELC MANAGEMENT LLC (US) 2024-12-03 US disclosed
CN-116808131-B Pharmaceutical composition, preparation method thereof and application of pharmaceutical composition in preventing and treating arteriosclerosis 右江民族医学院 2024-10-11 CN disclosed
CN-117242185-A Biocatalytic preparation of dihydrochalcone 西姆莱斯有限公司 2023-12-15 CN disclosed
CN-116808131-A Pharmaceutical composition, preparation method thereof and application of pharmaceutical composition in preventing and treating arteriosclerosis 右江民族医学院 2023-09-29 CN disclosed
CN-114887000-B Medicine application of lemongrass 云南农业大学 2023-09-26 CN disclosed
US-20230292754-A1 Pest Repellents and Uses Thereof UNIVERSITY OF CALIFORNIA RIVERSIDE 2023-09-21 US disclosed
EP-4228408-A1 PEST REPELLENTS AND USES THEREOF Sensorygen, Inc. (US) 2023-08-23 EP disclosed
WO-1999047118-A1 COMPOSITIONS FOR REGULATING SKIN APPEARANCE THE PROCTER & GAMBLE COMPANY (US) 1999-09-23 WO disclosed
EP-0872903-A1 Method for making hydrogen storage alloy powder and electrode comprising the alloy powder Shin-Etsu Chemical Co., Ltd. (JP) 1998-10-21 EP disclosed
EP-0139614-B1 PHARMACEUTICAL PREPARATIONS CONTAINING FLAVANONE OR THIOFLAVANONE DERIVATIVES, THE USE THEREOF, NOVEL FLAVANONES AND THIOFLAVANONES, AND PROCESSES FOR THEIR MANUFACTURE Zyma SA (CH) 1990-08-22 EP disclosed
US-4885298-A Pharmaceutical preparations containing flavanone or thioflavanone derivatives the use thereof, novel flavanones and thioflavanones, and processes for their manufacture ZYMA SA (CH) 1989-12-05 US disclosed
US-4758639-A Process for production of vinyl polymer SHIN-ETSU CHEMICAL CO., LTD. (JP) 1988-07-19 US disclosed
US-4757124-A Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments SHIN-ETSU CHEMICAL CO., LTD. (JP) 1988-07-12 US disclosed
EP-0172427-A2 Process for production of vinyl chloride polymer Shin-Etsu Chemical Co., Ltd. (JP) 1986-02-26 EP disclosed
EP-0139614-A2 Pharmaceutical preparations containing flavanone or thioflavanone derivatives, the use thereof, novel flavanones and thioflavanones, and processes for their manufacture Zyma SA (CH) 1985-05-02 EP disclosed
EP-0031885-B1 BASIC ETHERS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR THEIR PREPARATION MERCK PATENT GmbH (DE) 1984-06-27 EP disclosed
EP-0031885-A1 Basic ethers, pharmaceutical compositions containing them and process for their preparation MERCK PATENT GmbH (DE) 1981-07-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260033492-A1 Pest Repellents and Uses Thereof F3, TFPI, FLI1 CYP19A1 2958/4885ADORA3 4878/4885AR 4093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.